Skip to main content Skip to Footer

A helping hand for patients

Enhanced patient experience with mobile tech

Diagnosis of a rare, chronic disease can be isolating. Patients need robust support and information to help them manage a condition over their lifetime. With this need in mind, Shire, a global pharmaceutical company, wanted to empower patients and their caregivers with the knowledge and tools to help them manage care. Improving its patient services program would bring best-in-class care to rare disease patients and engage with them in innovative ways. Shire collaborated with Accenture to create a mobile application that creates a better
patient experience to:

  • Interact directly with case managers.

  • Connect to external resources relevant to their disease.

  • Track and update own patient information

  • Monitor their disease symptoms and health events.

  • Improve the quality of conversations with healthcare practitioners



ROBUST SUPPORT
FOR RARE DISEASES

Patients with rare medical conditions benefit from robust support. Since patient populations are relatively small, reliable information is often thin on the ground. Shire wanted to offer its patients a helping hand to navigate pathways to treatment. Strengthening its patient services program would help bring best-in-class care to niche patients across products, give patients the flexibility to talk with Shire across channels, and engage in innovative ways. Shire collaborated with Accenture to create a mobile application that connects patients to its Patient Services program, as well as other available resources. At launch, the app would serve patients using seven rare disease products, consolidating multiple sources of information in one spot. With the app, patients could take charge in managing their disease and reach out to Shire for support in the best way that suits them.

MOBILE SOLUTION FOR
THE PATIENT JOURNEY

Shire tapped into Accenture’s consulting, technology, cloud, and digital capabilities to develop and deliver the mobile application, which is built on Accenture’s Intelligent Patient Platform, extending the existing capabilities on Salesforce. The Accenture team worked closely with seven rare disease product brand teams to understand the patient’s journey and translate it into a user-friendly design. The platform integrates with Shire’s other customer-facing services, such as text and phone calls, enabling patients to contact case managers directly.

Patients can use the app to track insurance and provider information, find resources for financial support, and arrange infusion or injection training from a nurse. It also connects patients to external resources relevant to their disease, such as the product’s website, disease education, and patient support. With the mobile app, patients can track and update their personal information, as well as monitor disease symptoms and health events via an e-diary. Patients can export the e-diary to improve the quality of conversations with their healthcare practitioner.

DELIVERING A BETTER
PATIENT EXPERIENCE

The application is helping Shire deliver a better patient experience and remove barriers to treatment through mobile technology. It offers new ways to interact directly with patients and educate them on their disease. The company is working to make the mobile app technology standard across its portfolio of products to improve the experience for all Shire patients.

For patients and caregivers, the app puts knowledge and power in their hands. It allows users to manage their disease and track their patient information, receive patient support and disease information, and advance and enhance the quality of conversations with healthcare practitioners. These resources will allow patients to track when they experience episodes and monitor their lifestyle to minimize relapses, ultimately improving outcomes. Patients using the app now have more options to interact with Shire and other disease resources. With these enhanced connections, Shire is offering services that are more attuned to patient needs throughout the treatment journey.

SUGGESTED CONTENT